Safety, pharmacokinetics and use of the novel NK‐1 receptor antagonist maropitant (Cerenia TM ) for the prevention of emesis and motion sickness in cats
Year: 2008
Type: article
Authors: M. A. HICKMAN, S. R. COX, S. MAHABIR, C. MISKELL, J. LIN, A. BUNGER, R. B. McCALL
Institution: Pfizer (United States)
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2054906410